| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
|
Arch Neurol
|
2002
|
4.03
|
|
2
|
Efficacy of community-based physiotherapy networks for patients with Parkinson's disease: a cluster-randomised trial.
|
Lancet Neurol
|
2009
|
2.01
|
|
3
|
Hypocretin (orexin) loss in Parkinson's disease.
|
Brain
|
2007
|
1.98
|
|
4
|
Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait.
|
Brain
|
2010
|
1.76
|
|
5
|
Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy.
|
Nat Genet
|
2010
|
1.67
|
|
6
|
Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT).
|
Lancet Neurol
|
2013
|
1.60
|
|
7
|
Promotion of physical activity and fitness in sedentary patients with Parkinson's disease: randomised controlled trial.
|
BMJ
|
2013
|
1.57
|
|
8
|
ImmunoChip study implicates antigen presentation to T cells in narcolepsy.
|
PLoS Genet
|
2013
|
1.55
|
|
9
|
Effectiveness of multidisciplinary care for Parkinson's disease: a randomized, controlled trial.
|
Mov Disord
|
2012
|
1.54
|
|
10
|
Muscle ultrasonography: a diagnostic tool for amyotrophic lateral sclerosis.
|
Clin Neurophysiol
|
2012
|
1.52
|
|
11
|
Hypocretin/orexin disturbances in neurological disorders.
|
Sleep Med Rev
|
2008
|
1.45
|
|
12
|
The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.
|
Vaccine
|
2012
|
1.41
|
|
13
|
Normal values for quantitative muscle ultrasonography in adults.
|
Muscle Nerve
|
2010
|
1.24
|
|
14
|
Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity.
|
Obes Res
|
2003
|
1.19
|
|
15
|
Expectancy induces dynamic modulation of corticospinal excitability.
|
J Cogn Neurosci
|
2007
|
1.17
|
|
16
|
Corticospinal beta-band synchronization entails rhythmic gain modulation.
|
J Neurosci
|
2010
|
1.17
|
|
17
|
The ParkinsonNet concept: development, implementation and initial experience.
|
Mov Disord
|
2010
|
1.08
|
|
18
|
Body mass index in Parkinson's disease: a meta-analysis.
|
Parkinsonism Relat Disord
|
2011
|
1.07
|
|
19
|
Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study.
|
J Sleep Res
|
2013
|
1.07
|
|
20
|
Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia.
|
Gen Hosp Psychiatry
|
2009
|
1.06
|
|
21
|
Hypocretin (orexin) loss in Alzheimer's disease.
|
Neurobiol Aging
|
2011
|
1.05
|
|
22
|
Altered skin-temperature regulation in narcolepsy relates to sleep propensity.
|
Sleep
|
2006
|
1.05
|
|
23
|
The inferior frontal cortex in artificial syntax processing: an rTMS study.
|
Brain Res
|
2008
|
1.04
|
|
24
|
Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2.
|
J Neurol Neurosurg Psychiatry
|
2010
|
1.03
|
|
25
|
Reciprocal interactions between sleep, circadian rhythms and Alzheimer's disease: focus on the role of hypocretin and melatonin.
|
Ageing Res Rev
|
2012
|
1.01
|
|
26
|
The role of personality traits in insomnia.
|
Sleep Med Rev
|
2009
|
1.01
|
|
27
|
Physical inactivity in Parkinson's disease.
|
J Neurol
|
2011
|
1.00
|
|
28
|
Increased heart rate variability but normal resting metabolic rate in hypocretin/orexin-deficient human narcolepsy.
|
J Clin Sleep Med
|
2008
|
0.99
|
|
29
|
Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls.
|
Am J Physiol Endocrinol Metab
|
2011
|
0.99
|
|
30
|
Risk factors and prognosis of young stroke. The FUTURE study: a prospective cohort study. Study rationale and protocol.
|
BMC Neurol
|
2011
|
0.97
|
|
31
|
Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).
|
Arch Neurol
|
2011
|
0.97
|
|
32
|
Hypocretin and melanin-concentrating hormone in patients with Huntington disease.
|
Brain Pathol
|
2008
|
0.95
|
|
33
|
First trial postural reactions to unexpected balance disturbances: a comparison with the acoustic startle reaction.
|
J Neurophysiol
|
2010
|
0.95
|
|
34
|
Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation.
|
Vaccine
|
2012
|
0.93
|
|
35
|
Anxiety and mood disorders in narcolepsy: a case-control study.
|
Gen Hosp Psychiatry
|
2009
|
0.92
|
|
36
|
Allied health care in Parkinson's disease: referral, consultation, and professional expertise.
|
Mov Disord
|
2009
|
0.90
|
|
37
|
Directional sensitivity of "first trial" reactions in human balance control.
|
J Neurophysiol
|
2009
|
0.90
|
|
38
|
Quantitative muscle ultrasonography in amyotrophic lateral sclerosis.
|
Ultrasound Med Biol
|
2007
|
0.90
|
|
39
|
Design and baseline characteristics of the ParkFit study, a randomized controlled trial evaluating the effectiveness of a multifaceted behavioral program to increase physical activity in Parkinson patients.
|
BMC Neurol
|
2010
|
0.90
|
|
40
|
"Sleep benefit" in Parkinson's disease: a systematic review.
|
Parkinsonism Relat Disord
|
2013
|
0.90
|
|
41
|
Muscle changes in amyotrophic lateral sclerosis: a longitudinal ultrasonography study.
|
Clin Neurophysiol
|
2011
|
0.89
|
|
42
|
Manipulation of core body and skin temperature improves vigilance and maintenance of wakefulness in narcolepsy.
|
Sleep
|
2008
|
0.88
|
|
43
|
Possible confusion between primary hypersomnia and adult attention-deficit/hyperactivity disorder.
|
Psychiatry Res
|
2006
|
0.88
|
|
44
|
Prevalence and distribution of fasciculations in healthy adults: Effect of age, caffeine consumption and exercise.
|
Amyotroph Lateral Scler
|
2010
|
0.87
|
|
45
|
Choice reaction times for human head rotations are shortened by startling acoustic stimuli, irrespective of stimulus direction.
|
J Physiol
|
2007
|
0.87
|
|
46
|
Muscle ultrasonography to predict survival in amyotrophic lateral sclerosis.
|
J Neurol Neurosurg Psychiatry
|
2010
|
0.87
|
|
47
|
Behavioural hyperventilation as a novel clinical condition associated with central sleep apnoea: a report of three cases.
|
Sleep Med
|
2012
|
0.87
|
|
48
|
Evaluation of the falls telephone: an automated system for enduring assessment of falls.
|
J Am Geriatr Soc
|
2011
|
0.85
|
|
49
|
Timed motor tests can detect subtle motor dysfunction in early Parkinson's disease.
|
Mov Disord
|
2010
|
0.85
|
|
50
|
Association between hypocretin-1 and amyloid-β42 cerebrospinal fluid levels in Alzheimer's disease and healthy controls.
|
Curr Alzheimer Res
|
2012
|
0.85
|
|
51
|
Muscle imaging: mapping responses to transcranial magnetic stimulation with high-density surface electromyography.
|
Cortex
|
2007
|
0.85
|
|
52
|
Sleep benefit in Parkinson's disease: time to revive an enigma?
|
J Parkinsons Dis
|
2012
|
0.84
|
|
53
|
The possible price of auditory cueing: influence on obstacle avoidance in Parkinson's disease.
|
Mov Disord
|
2012
|
0.84
|
|
54
|
Narcolepsy and familial advanced sleep-phase syndrome: molecular genetics of sleep disorders.
|
Curr Opin Genet Dev
|
2007
|
0.83
|
|
55
|
A case of neuromuscular mimicry.
|
Neuromuscul Disord
|
2006
|
0.83
|
|
56
|
Rise and fall of skeletal muscle size over the entire life span.
|
J Am Geriatr Soc
|
2007
|
0.81
|
|
57
|
Nocturnal hypokinesia and sleep quality in Parkinson's disease.
|
J Am Geriatr Soc
|
2012
|
0.81
|
|
58
|
Severe fatigue in narcolepsy with cataplexy.
|
J Sleep Res
|
2011
|
0.81
|
|
59
|
Altered setting of the pituitary-thyroid ensemble in hypocretin-deficient narcoleptic men.
|
Am J Physiol Endocrinol Metab
|
2004
|
0.81
|
|
60
|
Recognition and diagnosis of sleep disorders in Parkinson's disease.
|
J Neurol
|
2012
|
0.80
|
|
61
|
Changes in corticospinal excitability and the direction of evoked movements during motor preparation: a TMS study.
|
BMC Neurosci
|
2008
|
0.79
|
|
62
|
CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis.
|
Amyotroph Lateral Scler
|
2009
|
0.79
|
|
63
|
Hypocretin (orexin) loss and sleep disturbances in Parkinson's Disease.
|
Brain
|
2007
|
0.79
|
|
64
|
Subjectively impaired bed mobility in Parkinson disease affects sleep efficiency.
|
Sleep Med
|
2013
|
0.78
|
|
65
|
The effect of exogenous cortisol during sleep on the behavioral and neural correlates of emotional memory consolidation in humans.
|
Psychoneuroendocrinology
|
2013
|
0.78
|
|
66
|
Plasma total ghrelin and leptin levels in human narcolepsy and matched healthy controls: basal concentrations and response to sodium oxybate.
|
J Clin Sleep Med
|
2013
|
0.78
|
|
67
|
Re: Silber MH, Krahn LE, Olson EJ. Diagnosing narcolepsy: validity and reliability of new diagnostic criteria. Sleep Med. 2002 Mar;3(2):109-13.
|
Sleep Med
|
2002
|
0.77
|
|
68
|
Intramuscular fibrous tissue determines muscle echo intensity in amyotrophic lateral sclerosis.
|
Muscle Nerve
|
2012
|
0.76
|
|
69
|
[Nocturnal stridor in multiple system atrophy].
|
Ned Tijdschr Geneeskd
|
2011
|
0.76
|
|
70
|
Altered circadian rhythm of melatonin concentrations in hypocretin-deficient men.
|
Chronobiol Int
|
2012
|
0.76
|
|
71
|
Sodium oxybate increases prolactin secretion in narcolepsy patients and healthy controls.
|
Eur J Endocrinol
|
2010
|
0.76
|
|
72
|
Pharmacological management of narcolepsy.
|
Expert Opin Pharmacother
|
2003
|
0.75
|
|
73
|
The ParkinsonNet trial: design and baseline characteristics.
|
Mov Disord
|
2010
|
0.75
|
|
74
|
Hypocretin-1 deficiency in a girl with ROHHAD syndrome.
|
Pediatrics
|
2013
|
0.75
|
|
75
|
Photoplethysmography beat detection and pulse morphology quality assessment for signal reliability estimation.
|
Conf Proc IEEE Eng Med Biol Soc
|
2017
|
0.75
|
|
76
|
Psychiatric comorbidity and aspects of cognitive coping negatively predict outcome in cognitive behavioral treatment of psychophysiological insomnia.
|
Behav Sleep Med
|
2014
|
0.75
|
|
77
|
Measuring the cortical silent period can increase diagnostic confidence for amyotrophic lateral sclerosis.
|
Amyotroph Lateral Scler
|
2007
|
0.75
|
|
78
|
Cumulative effect of 5 daily sessions of θ burst stimulation on corticospinal excitability in amyotrophic lateral sclerosis.
|
Muscle Nerve
|
2013
|
0.75
|